Source Post
6/27 - ONE DAY TO INMB
Jun 27, 2025
The creator discusses Inmune Therapeutics (INMB), expressing strong negative sentiment due to potential data issues and a recent PIPE offering. He questions the legality and timing of the offering, suggesting it implies the company is out of money and that the drugs may not be working. He believes both scenarios (good or bad data) lead to legal trouble for the company and investors.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.